Average Co-Inventor Count = 8.55
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property (no.2) Limited (9 from 92 patents)
2. Other (2 from 832,843 patents)
3. Glaxo Group Limited (1 from 1,168 patents)
4. Glaxosmithkline LLC (1 from 356 patents)
13 patents:
1. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
2. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors
3. 10583139 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
4. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
5. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors
6. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors
7. 10059699 - Tetrahydroquinoline derivatives as bromodomain inhibitors
8. 10034881 - 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
9. 9670221 - Furopyridines as bromodomain inhibitors
10. 9663533 - Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
11. 9637456 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
12. 7615550 - Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
13. 7285563 - Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain